Evidence map›Paper›PMID 38924395›Full record

ArticleScience advances2024

A chimeric membrane enzyme and an engineered whole-cell biocatalyst for efficient 1-alkene production.

Tabish Iqbal, Subhashini Murugan, Debasis Das

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tabish IqbalDepartment of Inorganic and Physical Chemistry, Indian Institute of Science, Bangalore, Karnataka 560012, India.ORCID 0000-0002-2479-8729
Subhashini MuruganDepartment of Inorganic and Physical Chemistry, Indian Institute of Science, Bangalore, Karnataka 560012, India.ORCID 0000-0002-4433-9191
Debasis DasDepartment of Inorganic and Physical Chemistry, Indian Institute of Science, Bangalore, Karnataka 560012, India.ORCID 0000-0001-8967-3348

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioproduction of 1-alkenes from naturally abundant free fatty acids offers a promising avenue toward the next generation of hydrocarbon-based biofuels and green commodity chemicals. UndB is the only known membrane-bound 1-alkene-producing enzyme, with great potential for 1-alkene bioproduction, but the enzyme exhibits limited turnovers, thus restricting its widespread usage. Here, we explore the molecular basis of the limitation of UndB activity and substantially improve its catalytic power. We establish that the enzyme undergoes peroxide-mediated rapid inactivation during catalysis. To counteract this inactivation, we engineered a chimeric membrane enzyme by conjugating UndB with catalase that protected UndB against peroxide and enhanced its number of turnovers tremendously. Notably, our chimeric enzyme is the only example of a membrane enzyme successfully engineered with catalase. We subsequently constructed a whole-cell biocatalytic system and achieved remarkable efficiencies (up to 95%) in the biotransformation of a wide range of fatty acids (both aliphatic and aromatic) into corresponding 1-alkenes with numerous biotechnological applications.

Indexed as

AlkenesBiocatalysisCatalaseEscherichia coliFatty AcidsProtein EngineeringRecombinant Fusion ProteinsAlkenesCatalaseFatty AcidsRecombinant Fusion Proteins

Identifiers

PMID38924395
PMCPMC11204201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.